ArticleThe Journal of clinical investigation2025

Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares.

James G Krueger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.